𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitoxantrone and VP-16 in refractory acute myelogenous leukemia

✍ Scribed by P. Meyer; A. D. Ho; Th. Lipp; G. Ehninger; H. Rückle; B. Steinke; W. Kaboth; W. Hunstein


Book ID
112785646
Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
134 KB
Volume
111
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Mitoxantrone and high-dose cytosine arab
✍ Ronald S. Walters; Hagop M. Kantarjian; Michael J. Keating; William K. Plunkett; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Forty-four patients with a diagnosis of refractory or relapsed acute myelogenous leukemia received salvage chemotherapy with high-dose cytosine arabinosine 3 g/m2 intravenously over 2 hours every 12 hours for six doses and mitoxantrone 5 mg/m2 intravenously daily for 5 days. Overall 16 patients (36%

Refractory acute lymphocytic leukemia: R
✍ Jacob M. Rowe; Alex Y. C. Chang; John M. Bennett 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

Twelve patients with acute lymphoblastic leukemia (ALL) were treated with aclacinomycin A (60 mg/m2/day for five days) and VP-16-213 (100 mg/m2/day). All were heavily pretreated and had relapsed or were refractory to primary or subsequent treatment. Eight patients were refractory to reinduction ther

Mitoxantrone in relapsed or refractory a
✍ Vredenburgh, James J. ;McLntyre, O. Ross ;Cornwell, Gibbons G. ;Ball, Edward D. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Seventeen patients with relapsed or refractory acute nonlymphocytic leukemia were treated with 14 mg/m2 of mitoxantrone given in a 30-minute infusion daily for three days. If the day fourteen bone marrow showed residual leukemia, a second course was given at the same dose for two days. Eight patient